+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Protein Drugs Market 2025 - Product Thumbnail Image

Protein Drugs Market 2025

  • Report
  • April 2025
  • 162 Pages
  • Global
From
PEGylated Proteins Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

PEGylated Proteins Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Biopharmaceutical Contract Manufacturing Market - Focused Insights 2024-2029 - Product Thumbnail Image

Biopharmaceutical Contract Manufacturing Market - Focused Insights 2024-2029

  • Report
  • January 2025
  • 163 Pages
  • Global
From
Single-use Technologies for Biopharmaceuticals Market - Product Thumbnail Image

Single-use Technologies for Biopharmaceuticals Market

  • Report
  • November 2024
  • 207 Pages
  • Global
From
Biopharmaceutical Market Outlook to 2029 - Product Thumbnail Image

Biopharmaceutical Market Outlook to 2029

  • Report
  • September 2024
  • 97 Pages
  • Global
From
Protein Purification & Isolation Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology, Application, and End-user - Product Thumbnail Image

Protein Purification & Isolation Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Technology, Application, and End-user

  • Report
  • September 2024
  • 115 Pages
  • Global
From
Biopharmaceutical Excipients Market - Focused Insights 2024-2029 - Product Thumbnail Image

Biopharmaceutical Excipients Market - Focused Insights 2024-2029

  • Report
  • August 2024
  • 163 Pages
  • Global
From
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029 - Product Thumbnail Image

Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024-2029

  • Report
  • June 2024
  • Global
From
Recombinant Proteins Market - Product Thumbnail Image

Recombinant Proteins Market

  • Report
  • June 2024
  • 108 Pages
  • Global
From
PEGylated Proteins Market 2023-2028 - Product Thumbnail Image

PEGylated Proteins Market 2023-2028

  • Report
  • April 2024
  • 74 Pages
  • Global
From
South Africa Biopharmaceuticals Market - Industry Outlook & Forecast 2023-2028 - Product Thumbnail Image

South Africa Biopharmaceuticals Market - Industry Outlook & Forecast 2023-2028

  • Report
  • August 2023
  • 202 Pages
  • South Africa
From
Global Biopharmaceuticals Market Outlook to 2027 - Product Thumbnail Image

Global Biopharmaceuticals Market Outlook to 2027

  • Report
  • July 2023
  • 80 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Biologics Development and Manufacturing Testing: Technologies and Global Markets - Product Thumbnail Image

Biologics Development and Manufacturing Testing: Technologies and Global Markets

  • Report
  • February 2023
  • 123 Pages
  • Global
From
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Biopharmaceutical Excipients Market - Global Outlook and Forecast 2022-2027 - Product Thumbnail Image

Biopharmaceutical Excipients Market - Global Outlook and Forecast 2022-2027

  • Report
  • July 2022
  • 317 Pages
  • Global
From
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 64 Pages
  • Global
From
Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 50 Pages
  • Global
From
Plasma Protein Therapeutics Market (2021 Edition) - Analysis By Product (Ig, Albumin, Factor VIII, Others), Application (Hemophilia, PID, ITP, Others), Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026) - Product Thumbnail Image

Plasma Protein Therapeutics Market (2021 Edition) - Analysis By Product (Ig, Albumin, Factor VIII, Others), Application (Hemophilia, PID, ITP, Others), Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • Report
  • October 2021
  • 190 Pages
  • Global
From
Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026 - Product Thumbnail Image

Global Markets and Manufacturing Technologies for Protein Drugs 2021-2026

  • Report
  • August 2021
  • 159 Pages
  • Global
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more